Journal article
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation
Abstract
BACKGROUND: Oral anticoagulants may improve the survival of people with cancer through both an antitumor effect and antithrombotic effect, yet increase the risk of bleeding.
OBJECTIVES: To evaluate the efficacy and safety of oral anticoagulants in ambulatory people with cancer undergoing chemotherapy, hormonal therapy, immunotherapy or radiotherapy, but otherwise have no standard therapeutic or prophylactic indication for anticoagulation.
Authors
Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA
Journal
Cochrane Database of Systematic Reviews, Vol. 12, No. 12,
Publisher
Wiley
DOI
10.1002/14651858.cd006466.pub6
ISSN
1361-6137